318 related articles for article (PubMed ID: 18497059)
1. Comparative analysis of SNP in estrogen-metabolizing enzymes for ovarian, endometrial, and breast cancers in Novosibirsk, Russia.
Gulyaeva LF; Mikhailova ON; PustyInyak VO; Kim IV; Gerasimov AV; Krasilnikov SE; Filipenko ML; Pechkovsky EV
Adv Exp Med Biol; 2008; 617():359-66. PubMed ID: 18497059
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphism of estrogen metabolizing enzymes in Siberian women with breast cancer.
Khvostova EP; Pustylnyak VO; Gulyaeva LF
Genet Test Mol Biomarkers; 2012 Mar; 16(3):167-73. PubMed ID: 21977969
[TBL] [Abstract][Full Text] [Related]
3. Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk.
Rebbeck TR; Troxel AB; Wang Y; Walker AH; Panossian S; Gallagher S; Shatalova EG; Blanchard R; Bunin G; DeMichele A; Rubin SC; Baumgarten M; Berlin M; Schinnar R; Berlin JA; Strom BL
J Natl Cancer Inst; 2006 Sep; 98(18):1311-20. PubMed ID: 16985250
[TBL] [Abstract][Full Text] [Related]
4. Estrogen-metabolizing gene polymorphisms in the assessment of female hormone-dependent cancer risk.
Mikhailova ON; Gulyaeva LF; Prudnikov AV; Gerasimov AV; Krasilnikov SE
Pharmacogenomics J; 2006; 6(3):189-93. PubMed ID: 16402077
[TBL] [Abstract][Full Text] [Related]
5. CYP1A1, SULT1A1, and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility.
Hirata H; Hinoda Y; Okayama N; Suehiro Y; Kawamoto K; Kikuno N; Rabban JT; Chen LM; Dahiya R
Cancer; 2008 May; 112(9):1964-73. PubMed ID: 18318428
[TBL] [Abstract][Full Text] [Related]
6. Adenomyosis: genetics of estrogen metabolism.
Artymuk N; Zotova O; Gulyaeva L
Horm Mol Biol Clin Investig; 2019 Mar; 37(2):. PubMed ID: 30878995
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of estrogen-metabolizing genes and breast cancer risk: a multigenic study.
Han DF; Zhou X; Hu MB; Xie W; Mao ZF; Chen DE; Liu F; Zheng F
Chin Med J (Engl); 2005 Sep; 118(18):1507-16. PubMed ID: 16232327
[TBL] [Abstract][Full Text] [Related]
8. CYP1A1 alleles in female genital cancers in the Polish population.
Seremak-Mrozikiewicz A; Drews K; Semczuk A; Jakowicki JA; Mrozikiewicz PM
Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):246-50. PubMed ID: 15653213
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms in estrogen-metabolizing genes and breast cancer survival.
Long JR; Cai Q; Shu XO; Cai H; Gao YT; Zheng W
Pharmacogenet Genomics; 2007 May; 17(5):331-8. PubMed ID: 17429315
[TBL] [Abstract][Full Text] [Related]
10. Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism.
Goodman MT; McDuffie K; Kolonel LN; Terada K; Donlon TA; Wilkens LR; Guo C; Le Marchand L
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):209-16. PubMed ID: 11303589
[TBL] [Abstract][Full Text] [Related]
11. Association of testicular germ cell tumor with polymorphisms in estrogen receptor and steroid metabolism genes.
Ferlin A; Ganz F; Pengo M; Selice R; Frigo AC; Foresta C
Endocr Relat Cancer; 2010 Mar; 17(1):17-25. PubMed ID: 19776291
[TBL] [Abstract][Full Text] [Related]
12. [Genetic polymorphism of steroidogenic enzymes and steroid receptor level in tumors of the reproductive system].
Berstein LM; Zimarina TS; Tsyrlina EV; Kovalevskiĭ AIu; Imianitov EN
Vopr Onkol; 2004; 50(2):169-73. PubMed ID: 15176218
[TBL] [Abstract][Full Text] [Related]
13. Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransferase 1A1, catechol-o-methyltransferase and tobacco exposure in breast cancer risk.
Saintot M; Malaveille C; Hautefeuille A; Gerber M
Int J Cancer; 2003 Nov; 107(4):652-7. PubMed ID: 14520706
[TBL] [Abstract][Full Text] [Related]
14. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
15. [Study on the relationship between polymorphisms of genes (CYP17, CYP19 and SULT1A1) and susceptibility to breast cancer in Chinese women].
Hu MB; Xie W; Xiong B; Han DF; Li Y; Feng MH; Zhou YF
Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Apr; 27(4):351-5. PubMed ID: 16875543
[TBL] [Abstract][Full Text] [Related]
16. Lack of association between the functional polymorphisms in the estrogen-metabolizing genes and risk for hepatocellular carcinoma.
Yuan X; Zhou G; Zhai Y; Xie W; Cui Y; Cao J; Zhi L; Zhang H; Yang H; Zhang X; Qiu W; Peng Y; Zhang X; Yu L; Xia X; He F
Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3621-7. PubMed ID: 19064581
[TBL] [Abstract][Full Text] [Related]
17. CYP1A1 and CYP1B1 polymorphisms and their association with estradiol and estrogen metabolites in women who are premenopausal and perimenopausal.
Sowers MR; Wilson AL; Kardia SR; Chu J; McConnell DS
Am J Med; 2006 Sep; 119(9 Suppl 1):S44-51. PubMed ID: 16949388
[TBL] [Abstract][Full Text] [Related]
18. Genetic factors in catechol estrogen metabolism in relation to the risk of endometrial cancer.
Doherty JA; Weiss NS; Freeman RJ; Dightman DA; Thornton PJ; Houck JR; Voigt LF; Rossing MA; Schwartz SM; Chen C
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):357-66. PubMed ID: 15734958
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women.
Sangrajrang S; Sato Y; Sakamoto H; Ohnami S; Laird NM; Khuhaprema T; Brennan P; Boffetta P; Yoshida T
Int J Cancer; 2009 Aug; 125(4):837-43. PubMed ID: 19415745
[TBL] [Abstract][Full Text] [Related]
20. An investigation of relationships between hypoxia-inducible factor-1 alpha gene polymorphisms and ovarian, cervical and endometrial cancers.
Konac E; Onen HI; Metindir J; Alp E; Biri AA; Ekmekci A
Cancer Detect Prev; 2007; 31(2):102-9. PubMed ID: 17418979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
